About the Study The study is a Phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of CANDIN (Candida albicans Skin Test Antigen for Cellular Hypersensitivity) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback